Hans Martin Schier

Title: The Innovations of Hans Martin Schier

Introduction

Hans Martin Schier is a notable inventor based in Strausberg, Germany. He has made significant contributions to the field of diagnostics and therapeutics through his innovative work. His research focuses on the development of metal-binding, cysteine-free peptides that have important applications in medical science.

Latest Patents

Hans Martin Schier holds a patent for "Metal-binding cysteine-free peptides for diagnostic and therapeutical purposes, methods for their production, and pharmaceuticals containing these compounds." This invention relates to metal-complexing, cysteine-free peptides that can be coupled to organ-specific probes, allowing for targeted enrichment in tumors, organs, tissues, or centers of inflammation. The organ-specific probes used include antibodies or parts of antibodies against tumor-associated antigens, such as the carcino-embryonal antigen (CEA). The invention also encompasses processes for producing these peptides and their conjugates, which can be utilized in kits for in vivo diagnosis or therapy, as well as in radio-pharmaceuticals containing radio-isotopes.

Career Highlights

Hans Martin Schier is associated with Institut für Diagnostikforschung GmbH, where he continues to advance his research and development efforts. His work has the potential to significantly impact the field of medical diagnostics and treatment.

Collaborations

Some of his notable coworkers include Renate Steinbrecher and Reinhard Malin, who have collaborated with him on various projects.

Conclusion

Hans Martin Schier's innovative contributions to the field of diagnostics and therapeutics highlight the importance of research in developing targeted medical solutions. His work with metal-binding peptides represents a significant advancement in the ability to diagnose and treat diseases effectively.